Albarado, Johnrey .
HRN: 18-59-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/31/2024
06/07/2024
IV
315mg
Q8
SEPSIS
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes